bFGF Inhibitory Peptide provides a sequence designed to interfere with basic fibroblast growth factor recognition. The peptide enables mechanistic evaluation of ligand-receptor complexes in controlled biochemical systems. Its architecture supports structure-activity studies and competitive binding assays. Researchers use it to dissect protein-protein interaction surfaces and regulatory motifs.
CAT No: B06002
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More